Evidence map›Paper›PMID 40126162›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Highly Absorbent Ultrafast Self-Gelling Starch Microparticles for Robust Wet-Tissue Adhesion and Instant Hemostasis.

Soohwan An, Jihoon Jeon, Seung Yeop Han, Mi Jeong Lee, Tae-Gyeong Oh, Eun Je Jeon, Dong Jin Joo, Seung-Woo Cho

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Soohwan AnDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Jihoon JeonDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Seung Yeop HanDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Mi Jeong LeeDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Tae-Gyeong OhDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Eun Je JeonCellArtgen Inc., Seoul, 03722, Republic of Korea.
Dong Jin JooDepartment of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Seung-Woo ChoDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.ORCID https://orcid.org/0000-0001-8058-332X

Funding

Brain Korea 21 (BK21) FOUR programCellArtgenNano & Material Technology Development Program, National Research Foundation of Korea, Ministry of Science and ICT RS-2024-00410437National Research Foundation of Korea, Ministry of Science and ICT RS-2021-NR059722Technology Innovation Program, Ministry of Trade, Industry and Energy 20024298Yonsei Fellow Program funded by Lee Youn Jae, Yonsei UniversityYonsei Signature Research Cluster Program, Yonsei University 2024-22-0165
6 · The paper itself

Abstract

Rapid and effective hemostasis of mass bleeding from irregularly shaped wounds remains a critical clinical challenge. Herein, a highly absorbent and self-gelling microparticle (MP) is reported based on modified starch as a hemostatic material with robust wet tissue adhesiveness. The aldehyde- and catechol-modified starch (ACS) is synthesized via partial oxidation of starch for the reduction of dense intermolecular interactions within starch, thereby significantly enhancing its interaction with water molecules. Moreover, the conjugated catechol group strengthens the affinity to various biomolecules. The ACS microparticle (ACS-MP) prepared by calcium intercalation into the polysaccharide chains and subsequent freeze-milling rapidly converts to a stable hydrogel within seconds upon hydration, exhibiting superior water absorption capacity and tissue adhesion. The ACS-MP demonstrates excellent in vivo biocompatibility in local and systemic administration. The application of ACS-MP to bleeding wounds enables rapid blood absorption and accumulation of blood components and coagulation factors. The ACS-MP can fill irregularly shaped wounds, forming a tissue-adhesive hydrogel in situ, thereby creating a physical barrier for non-compressible hemostasis. The superior hemostatic performance of ACS-MP against massive hemorrhage from liver injuries in mice and pigs is confirmed. The ACS-MP will be a promising hemostat for effectively controlling mass bleeding in various tissues in clinical settings.

Indexed as

HemorrhageHemostasisHemostaticsStarchAnimalsHydrogelsMiceSwineTissue AdhesionsHemostaticsHydrogelsStarchabsorbent & adhesive hydrogelhemostasismicroparticlestarchultrafast self‐gelation

Identifiers

PMID40126162
PMCPMC12097133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.